Clinical Trial: Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)

U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07582237) titled 'Long-Term Follow-up Study of FURESTEM-AD in Patients With Atopic Dermatitis(K0106)' on May 06.

Brief Summary: Long-Term Follow-up Study of Subjects With Moderate to Severe Chronic Atopic Dermatitis Who Had Administered FURESTEM-AD Inj. in K0106 Study

Study Start Date: Oct. 05, 2021

Study Type: OBSERVATIONAL

Condition: Dermatitis, Atopic

Recruitment Status: ACTIVE_NOT_RECRUITING

Sponsor: Kang Stem Biotech Co., Ltd.

Disclaimer: Curated by HT Syndication....